Zinc Supplementation Stimulates Tetanus Antibody Formation and Soluble Interleukin-2 Receptor Levels in Chronic Hemodialysis Patients

Overview

Journal Clin Investig

Specialty General Medicine

Date 1993 Jul 1

PMID 8374246

Citations 3

Authors

W Holtkamp

H P Brodersen

T Stollberg

J Thiery

C Falkner

Affiliations

Soon will be listed here.

Abstract

Immunodepression in end-stage renal disease has been associated with zinc deficiency. In a controlled study serum zinc levels, serum concentrations of soluble interleukin-2 receptor (sIL-2R), and tetanus IgG antibody titers were measured in 65 hemodialysis patients before and after intravenous zinc supplementation for 2 months. The hemodialysis patients had significantly lower predialysis serum zinc concentrations compared to healthy controls (63 +/- 1.65 versus 126 +/- 4.6 micrograms/dl, P < 0.001). Serum zinc concentrations increased to the normal range in the zinc-treated patients. After zinc substitution tetanus antibody titers rose significantly (0.81 +/- 0.12 versus 1.22 +/- 0.12 U/ml, P < 0.01). Pretreatment sIL-2R levels were elevated in 95% of examined patients. A further increase in sIL-2R was observed after zinc supplementation (234 +/- 14 versus 285 +/- 21 U/ml, P < 0.05). The results suggest that zinc induces the activation of T lymphocytes and T-cell dependent B lymphocytes in chronic uremic patients in vivo.

Citing Articles

The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysis.

Chen X, Li Y, Ding X, Zou J, Shen B, Liu Z Ren Fail. 2020; 42(1):419-427.

PMID: 32401100 PMC: 7269077. DOI: 10.1080/0886022X.2020.1761388.

Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.

Xiaohong C, Bo S, Fangfang X, Man G, Jianzhou Z, Zhonghua L Int J Clin Oncol. 2019; 24(9):1151-1160.

PMID: 31183777 DOI: 10.1007/s10147-019-01455-5.

Trace elements in hemodialysis patients: a systematic review and meta-analysis.

Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B BMC Med. 2009; 7:25.

PMID: 19454005 PMC: 2698829. DOI: 10.1186/1741-7015-7-25.

References

Cunningham-Rundles S, Cunningham-Rundles C, DuPont B, GOOD R . Zinc-induced activation of human B lymphocytes. Clin Immunol Immunopathol. 1980; 16(1):115-22. DOI: 10.1016/0090-1229(80)90172-5. View

Raskova J, Ghobrial I, Shea S, Ebert E, EISINGER R, RASKA Jr K . T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation. Diagn Immunol. 1986; 4(4):209-16. View

Fraker P, Zwickl C, LUECKE R . Delayed type hypersensitivity in zinc deficient adult mice: impairment and restoration of responsivity to dinitrofluorobenzene. J Nutr. 1982; 112(2):309-13. DOI: 10.1093/jn/112.2.309. View

Foote J, Hinks L . Reduced leucocyte zinc and albumin-bound zinc in blood of haemodialysis patients. Ann Clin Biochem. 1987; 24 ( Pt 2):198-202. DOI: 10.1177/000456328702400214. View

Ruiz P, Gomez F, Schreiber A . Impaired function of macrophage Fc gamma receptors in end-stage renal disease. N Engl J Med. 1990; 322(11):717-22. DOI: 10.1056/NEJM199003153221102. View

Briggs W, Pedersen M, Mahajan S, Sillix D, Prasad A, McDonald F . Lymphocyte and granulocyte function in zinc-treated and zinc-deficient hemodialysis patients. Kidney Int. 1982; 21(6):827-32. DOI: 10.1038/ki.1982.106. View

Guerin A, Buisson Y, Nutini M, Saliou P, London G, Marchais S . Response to vaccination against tetanus in chronic haemodialysed patients. Nephrol Dial Transplant. 1992; 7(4):323-6. DOI: 10.1093/oxfordjournals.ndt.a092136. View

Haynes D, Gershwin M, Golub M, Cheung A, Hurley L, Hendrickx A . Studies of marginal zinc deprivation in rhesus monkeys: VI. Influence on the immunohematology of infants in the first year. Am J Clin Nutr. 1985; 42(2):252-62. DOI: 10.1093/ajcn/42.2.252. View

Kohler H, Dumann H, Meyer zum Buschenfelde K, Meuer S . [Secondary immune deficiency in renal failure exemplified by hepatitis B vaccination]. Klin Wochenschr. 1988; 66(18):865-72. DOI: 10.1007/BF01728948. View

10.

Mahajan S, Prasad A, Lambujon J, Abbasi A, Briggs W, McDonald F . Improvement of uremic hypogeusia by zinc: a double-blind study. Am J Clin Nutr. 1980; 33(7):1517-21. DOI: 10.1093/ajcn/33.7.1517. View

11.

Antoniou L, SHALHOUB R, Schechter G . The effect of zinc on cellular immunity in chronic uremia. Am J Clin Nutr. 1981; 34(9):1912-7. DOI: 10.1093/ajcn/34.9.1912. View

12.

Dumann H, Meuer S, Kohler H . Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation. Nephron. 1990; 56(2):162-5. DOI: 10.1159/000186126. View

13.

Donati D, Degiannis D, Homer L, Gastaldi L, Raskova J, RASKA Jr K . Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. Nephron. 1991; 58(3):268-75. DOI: 10.1159/000186435. View

14.

Muirhead N, Kertesz A, Flanagan P, Hodsman A, Hollomby D, VALBERG L . Zinc metabolism in patients on maintenance hemodialysis. Am J Nephrol. 1986; 6(6):422-6. DOI: 10.1159/000167247. View

15.

Rubin L, Kurman C, FRITZ M, Biddison W, Boutin B, Yarchoan R . Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985; 135(5):3172-7. View

16.

Grekas D, Tsakalos N, Giannopoulos Z, Tourkantonis A . Effect of zinc treatment on cell mediated immunity of chronic renal failure patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985; 21:825-9. View

17.

LUECKE R, Simonel C, Fraker P . The effect of restricted dietary intake on the antibody mediated response of the zinc deficient A/J mouse. J Nutr. 1978; 108(5):881-7. DOI: 10.1093/jn/108.5.881. View

18.

Holtkamp W, Brodersen H, Thiery J, Falkner C, Bolzius R, Larbig D . [Effect of zinc substitution on lymphocyte subsets and cellular immune function in hemodialysis patients]. Klin Wochenschr. 1991; 69(9):392-6. DOI: 10.1007/BF01647412. View

19.

Chatenoud L, Dugas B, Beaurain G, Touam M, Drueke T, Vasquez A . Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. Proc Natl Acad Sci U S A. 1986; 83(19):7457-61. PMC: 386737. DOI: 10.1073/pnas.83.19.7457. View

20.

Margolis A, Kleinknecht C, Bonnissol C, GAIFFE M, Sahyoun S, Broyer M . [Serum antibodies before and after vaccination of hemodialyzed children. Preliminary results]. J Urol Nephrol (Paris). 1977; 83(9):700-4. View